Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EnteroTrack
Aurora, Colorado, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
EnteroTrack’s Esophageal String Test (EST) is clinically validated as a minimally invasive, highly sensitive tool for monitoring eosinophilic esophagitis (EoE), achieving disease activity assessment comparable to biopsy with high repeat acceptance and recent Medicare reimbursement approval.[1][5][7]
- Therapeutic areas
- Gastroenterology
- Modalities
- Device
- Industry
- Consumable Medical Devices
02
Partnerships
University of Colorado AnschutzChildren’s Hospital ColoradoMayo ClinicStanfordGlaxoSmithKlineUniversity of South Florida HospitalScripps Clinic
Beyond the preview
Go deeper on EnteroTrack.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EnteroTrack.